$39.79
0.070.18%
Last update: Jun 15, 10:58 AM
Centessa Pharmaceuticals PLC Earnings Estimates
CNTANASDAQ
Centessa Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:CNTA
Centessa Pharmaceuticals (CNTA) is scheduled to report Q2 earnings on August 11, 2026. Analysts estimate EPS of $-0.38 and quarterly revenue of N/A.
In the most recent quarter (Q1), Centessa Pharmaceuticals reported EPS of $-0.52, missing estimates of $-0.40 by 0.30%. Revenue came in at $0.00, missing the estimate of $382.18K by 1.00%.
Centessa Pharmaceuticals has missed EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, Centessa Pharmaceuticals has averaged an EPS surprise of 0.12% and a revenue surprise of 1.00%.
Earnings Date
Aug 11
EPS Estimate
$-0.380
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Centessa Pharmaceuticals Earnings History
Analyze the earnings history of Centessa Pharmaceuticals using advanced sorting and filters.
Loading calendar...
Centessa Pharmaceuticals (CNTA) Earnings Per Share
The chart below shows Centessa Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Centessa Pharmaceuticals (CNTA) Revenue
The chart below shows Centessa Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Centessa Pharmaceuticals (NASDAQ:CNTA) reporting earnings?
Centessa Pharmaceuticals (CNTA) is scheduled to report earnings on August 11, 2026. The last reported earnings were for reported on May 5, 2026 for Q1.
What were the latest earnings per share (EPS) for Centessa Pharmaceuticals (NASDAQ:CNTA)?
The Actual EPS was $-0.52, which missed the estimate of $-0.40.
What were Centessa Pharmaceuticals’s (NASDAQ:CNTA) revenues?
The Actual Revenue was $0.00, which missed the estimate of $382.18K.
